Publication:
The under-reported role of toxic substance exposures in the COVID-19 pandemic.

dc.contributor.authorKostoff, Ronald N
dc.contributor.authorBriggs, Michael B
dc.contributor.authorPorter, Alan L
dc.contributor.authorHernández, Antonio F
dc.contributor.authorAbdollahi, Mohammad
dc.contributor.authorAschner, Michael
dc.contributor.authorTsatsakis, Aristidis
dc.date.accessioned2023-02-09T09:38:41Z
dc.date.available2023-02-09T09:38:41Z
dc.date.issued2020-08-14
dc.description.abstractCoronavirus disease 2019 (COVID-19) and previous pandemics have been viewed almost exclusively as virology problems, with toxicology problems mostly being ignored. This perspective is not supported by the evolution of COVID-19, where the impact of real-life exposures to multiple toxic stressors degrading the immune system is followed by the SARS-CoV-2 virus exploiting the degraded immune system to trigger a chain of events ultimately leading to COVID-19. This immune system degradation from multiple toxic stressors (chemical, physical, biological, psychosocial stressors) means that attribution of serious consequences from COVID-19 should be made to the virus-toxic stressors nexus, not to any of the nexus constituents in isolation. The leading toxic stressors (identified in this study as contributing to COVID-19) are pervasive, contributing to myriad chronic diseases as well as immune system degradation. They increase the likelihood for comorbidities and mortality associated with COVID-19. For the short-term, tactical/reactive virology-focused treatments are of higher priority than strategic/proactive toxicology-focused treatments, although both could be implemented in parallel to reinforce each other. However, for long-term pandemic prevention, toxicology-based approaches should be given higher priority than virology-based approaches. Since current COVID-19 treatments globally ignore the toxicology component almost completely, only limited benefits can be expected from these treatments.
dc.identifier.doi10.1016/j.fct.2020.111687
dc.identifier.essn1873-6351
dc.identifier.pmcPMC7426727
dc.identifier.pmid32805343
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426727/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.fct.2020.111687
dc.identifier.urihttp://hdl.handle.net/10668/16113
dc.journal.titleFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association
dc.journal.titleabbreviationFood Chem Toxicol
dc.language.isoen
dc.organizationIBS
dc.page.number111687
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rights.accessRightsopen access
dc.subjectCOVID-19
dc.subjectContributing factors
dc.subjectImmune system
dc.subjectPandemic
dc.subjectSARS-CoV-2
dc.subjectToxic mixture
dc.subject.meshBetacoronavirus
dc.subject.meshCOVID-19
dc.subject.meshCoronavirus Infections
dc.subject.meshHazardous Substances
dc.subject.meshHealthy Lifestyle
dc.subject.meshHumans
dc.subject.meshPandemics
dc.subject.meshPneumonia, Viral
dc.subject.meshQuarantine
dc.subject.meshSARS-CoV-2
dc.titleThe under-reported role of toxic substance exposures in the COVID-19 pandemic.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number145
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7426727.pdf
Size:
932.36 KB
Format:
Adobe Portable Document Format